Matthew Galsky

Feinstein Institute For Medical Research

$2,931,105

Attributed

$5,347,082

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $983.8K · FY2015–25

$1M$750K$500K$250K$0

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,347,082 · 5

By mechanism

R01$3,453,690 · 1

P30$1,443,615 · 3

R21$449,777 · 1

Top collaborators

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsClinical TrialsOncologistResearch PersonnelMultidisciplinaryEventStructureMalignant Neoplasm Of Urinary BladderCancer PatientProtocols DocumentationEvidence BaseUrologistInnovationTrainingHigh RiskCommunicationResourcesCancer TherapyOncologyNew Therapeutic TargetBiological MarkersMemberImmunologyCancer Center Support Grant